Literature DB >> 18081704

Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1).

H Tamary1, H Offret, O Dgany, B Foliguet, S N Wickramasinghe, T Krasnov, F Rumilly, C Goujard, M Fénéant-Thibault, T Cynober, J Delaunay.   

Abstract

A congenital dyserythropoietic anaemia (CDA) was recognised in a French Caucasian male patient. Blood smears showed a pronounced aniso-poikilocytosis. Bone marrow light microscopy showed signs of dyserythropoesis, but no internuclear chromatin bridges. Electron microscopy disclosed erythroblast nuclei with the Swiss cheese aspect and the presence of cytoplasmic organelles, assessing the diagnosis of CDA I. The presence of internuclear chromatin bridges may thus be missing in CDA I. The patient proved to be homozygous for the Arg1042Trp mutation in codanin-1 (the 'Bedouin mutation'). By the age of 25, the patient's vision started to deteriorate as a result of retinal angioid streaks and macular abnormalities. Evolution was controlled and the patient, being nearly 50 yr old now, still has a partial use of his eyes. This second case of retinal angioid streaks reported in CDA I adds to the non-haematological features likely to be associated with this condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081704     DOI: 10.1111/j.1600-0609.2007.01004.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  8 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

2.  Close to unraveling the secrets of congenital dyserythropoietic anemia types I and II.

Authors:  Achille Iolascon; Jean Delaunay
Journal:  Haematologica       Date:  2009-05       Impact factor: 9.941

3.  Stem cell transplantation for congenital dyserythropoietic anemia: an analysis from the European Society for Blood and Marrow Transplantation.

Authors:  Maurizio Miano; Dirk-Jan Eikema; Mahmoud Aljurf; Pieter J Van't Veer; Gülyüz Öztürk; Matthias Wölfl; Frans Smiers; Angsar Schulz; Gerard Socié; Kim Vettenranta; Cristina Diaz de Heredia; Marco Zecca; Johan Maertens; Montserrat Rovira; Jorge Sierra; Duygu Uckan-Cetinkaya; Elena Skorobogatova; Ali Bülent Antmen; Jean-Hugues Dalle; Miroslaw Markiewicz; Rose Marie Hamladji; Vassiliki Kitra-Roussou; Giorgio La Nasa; Gergely Kriván; Amal Al-Seiraihy; Stefano Giardino; Antonio Maria Risitano; Regis Peffault de Latour; Carlo Dufour
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

Review 4.  The congenital dyserythropoieitic anemias: genetics and pathophysiology.

Authors:  Richard King; Patrick J Gallagher; Rami Khoriaty
Journal:  Curr Opin Hematol       Date:  2021-12-24       Impact factor: 3.218

5.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

6.  Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation.

Authors:  Hak Sung Lee; Jae-Hyun Jun; Eun-Ha Jung; Bon Am Koo; Yeong Shik Kim
Journal:  Molecules       Date:  2014-08-13       Impact factor: 4.411

7.  A Case of Angioid Streaks in Congenital Dyserythropoietic Anaemia Type II.

Authors:  Emer Doolan; Andrea Ryan
Journal:  Case Rep Ophthalmol       Date:  2022-01-11

Review 8.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.

Authors:  Achille Iolascon; Maria Rosaria Esposito; Roberta Russo
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.